SPA70
CAS No. 931314-31-7
SPA70 ( —— )
Catalog No. M28349 CAS No. 931314-31-7
SPA70 is a selective pregnane X receptor (PXR) antagonist with an IC50 of 540 nM and Ki of 390 nM for human PCR and enhances the chemosensitivity of cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 115 | Get Quote |
|
10MG | 165 | Get Quote |
|
25MG | 263 | Get Quote |
|
50MG | 403 | Get Quote |
|
100MG | 592 | Get Quote |
|
500MG | 1242 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSPA70
-
NoteResearch use only, not for human use.
-
Brief DescriptionSPA70 is a selective pregnane X receptor (PXR) antagonist with an IC50 of 540 nM and Ki of 390 nM for human PCR and enhances the chemosensitivity of cancer cells.
-
DescriptionSPA70 is a selective pregnane X receptor (PXR) antagonist with an IC50 of 540 nM and Ki of 390 nM for human PCR and enhances the chemosensitivity of cancer cells.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number931314-31-7
-
Formula Weight415.5
-
Molecular FormulaC21H25N3O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(OC)c(c1)-n1nnc(c1C)S(=O)(=O)c1ccc(cc1)C(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Huke M, G?rlitzer K, Schenck G. Polyhydroxyaurone. 3. Systematische Charakterisierung durch UV-Spektroskopie und Dünnschicht-Chromatographie [Polyhydroxyaurones. 3. Systematic characterization by UV-spectroscopy and thin layer chromatography]. Arch Pharm Ber Dtsch Pharm Ges. 1969 Jun;302(6):401-22. German.
molnova catalog
related products
-
62'-Dihydroxyflavone
62'-Dihydroxyflavone is a novel antagonist of GABAA receptor.
-
Kaolin
Kaolin is a clay dominated by minerals of the kaolinite family. Kaolin increased the sensitivity of this method for monitoring hemophilia therapy.
-
Cyanidin-3,5-O-diglu...
Cyanidin-3,5-O-diglucoside chloride has antioxidant activity. Cyanidin-3,5-O-diglucoside inhibits hyperbaric pressure-induced GLAST decrease and can be used in glaucoma studies.